WE HAVE RECENTLY reported the characterization and localization of a glycoprotein (NSA3) associated with the nervous system (Delpech et al., 1976a) . This glycoprotein was found to be comparable to the "brain-specific 02 glycoprotein" of Warecka & Bauer (1967) . Exchange of antisera and purified antigens between the laboratories allowed the identification of the 2 antigens. The systematic search for the antigen in tumours led to our discovery of its presence in nonnervous tumours (Delpech et al., 1976b) . This discovery, in conjunction with the observation that cancer patients' lymphocytes could be sensitized to an antigen in the normal nervous system (Field & Caspary, 1970) , led us to attempt to elucidate the immunochemical and immunohistological characteristics of the antigen foun'd in non-nervous tumours. We show here that this component, which is antigenically close to NSA3, is a glycoprotein which is associated with foetal and tumour mesenchyme (mesenchyme-associated antigen or MAA).
MATERIAL AND METHODS
Tumours and organs.-The tumours are listed in Table I . They were obtained by surgery. When practicable, the tumours were divided into 3 parts: one for histological study, another for immunofluorescence study, and the third for immunochemical study. Apparently normal organs, also listed in Table I , were obtained during necropsy performed less than 6 h after death. Organ and tumour extracts were obtained by grinding the tissues in PBS (NaCl 8 g/l with OO1M phosphate at pH 7.4) with an Ultra-Turrax.
The mixture was centrifuged for 10 min at 32,000 g. The supernatants were collected, dialysed against deionized water and lyophilized. Foetuses were obtained from spontaneous abortions at 3-4 months' gestation. Organs were extracted as described above.
Lyophilized samples were reintroduced into PBS in concentrations of 50 or 100 mg/ml. The portion that remained insoluble after centrifugation at 12,000 g was discarded. The proteins in the supernatant were assayed by the Lowry technique.
Fibroblast culture.-Granuloma fibroblasts were cultured in RPMI (Eurobio) containing 10% foetal calf serum, in a 5% C02-enriched atmosphere. The antigen was sought after sonication of a 0Iml pellet reintroduced into 0-1 ml PBS, and in the culture medium after 2 days' growth in the absence of foetal serum. Fibroblasts were also cultured on glass slides and acetone-fixed at -20°C for immunofluorescence studies.
Purification of antigens.-NSA3 was prepared in 2 steps. First, cerebral extract was reintroduced into PBS (50 mg/ml) and submitted to 6B Sepharose chromatography (Delpech et al., 1976) . The initial peaks from 3 chromatographic runs were pooled and dialysed against 5 1 of 01M phosphate buffer (pH 5). After centrifugation, the insoluble portion was discarded and the supernatant was neutralized with NaOH to a final pH of 7. This adjusted supernatant was incubated for 48 h at room temperature with the anti-liver serum polymer (1 g of moist polymer to 1 mg of protein), the polymer was rinsed with PBS, and the antigen precipitated out from the effluent with 50%-saturated ammonium sulphate. This precipitate was reintroduced into deionized water, dialysed against deionized water and lyophilized. In the second step, rabbits were inoculated with this antigen (see below). The antiserum obtained was absorbed out with liver extract and polymerized. This polymer was used to isolate the cerebral antigen from the fraction of crude brain extract soluble at pH 5 (3-4 mg of proteins/g of moist polymer). After 48h incubation at room temperature, the polymer was washed in PBS until the optical density reached 0 05 at 280 nm. The polymer was then packed in a 60ml syringe and treated with pH 2-8 glycerine-HCI buffer at a flow rate of 5-10 ml/h. Protein elution was continuously registered. The eluate was dialysed against deionized water, then against twice distilled water (100 volumes) and lyophilized. The same method was used to obtain NSA3 from the fibrosarcoma-absorbed polymerized anti-NSA3 serum (Polymer No. 2; see below) .
Mesenchymal antigen was similarly prepared from a fibrosarcoma and from a breast adenoma with No. 1 anti-NSA3 polymer. The preparations obtained with 60 g of polymer incubated with 200 mg of proteins weighed from 0 5 to 1 mg. The purity of these preparations was evaluated by double immunodiffusion, acrylamide-agarose chromatography and inoculation into rabbits.
Human skin collagen was isolated by the technique of Rothbard & Watson (1972) .
Collagen was extracted from skin with 0.5% acetic acid, precipitated at pH 7*3, washed in deionized water, and lyophilized.
Antisera.-Antisera were prepared in rabbits against organ extracts (brain, liver) and purified antigens (NSA3, fibrosarcoma MAA and breast adenoma MAA). The antigenic preparation (50 mg of lyophilized organ extract or 1 mg of purified antigen) was introduced into 0 5 ml of PBS, emulsified in 0 5 ml of Freund's complete adjuvant, and then injected s.c. Starting at the 4th week after injection, the injections were repeated weekly until the desired activity was achieved. Once a week the rabbits were bled from the ear vein.
In order to be certain of our sera's specific reactivity (anti-NSA3 or anti-MAA), steps were always taken to eliminate any antibodies directed against non-organ-specific antigens. Antisera were absorbed with 50 mg of plasma proteins and 50-100 mg of hepatic extract per ml. After 24 h at room temperature, the preparation was centrifuged (12,000 g for 10 min) and stored at -30°C. This product was used for the rapid study by immunodiffusion of the antiserum activity. The specific antiserum used either for the immunofluorescent studies or for the antigen estimation was cleared of common antibodies on a mixed plasma/organ extract polymer. The antiserum was incubated with 1 g/ml of moist polymer for 48 h at room temperature. The polymer was then washed with PBS until the optical density reached 0 05 at 280 nm. After precipitation in 40% saturated ammonium sulphate, the gamma globulins were washed once and reintroduced into a PBS volume equal to half the initial volume and dialysed against PBS. Aliquots (0-5 ml) were collected and stored at -76°C. The quality of the purified anti-NSA3 was verified by double immunodiffusion against lyophilized cerebral, hepatic and splenic extract reintroduced into PBS at a concentration of 50 mg/ml, and serially diluted to a final dilution of 1: 32. On staining, no precipitation line was noted with either liver extract or spleen extract. (1969) . Glial fibrillary acidic protein (GFA) and antiserum were prepared as described earlier (Delpech et al., 1978) . Antifibronectin antiserum was obtained from Behring Institut.
Immunosorbents.-Polymers were prepared with glutaraldehyde and regenerated according to the method described by Avrameas & Ternynck (1969) . Mixed human plasma and organ polymer were prepared from a mixture consisting of 3 parts plasma to 1 part each of liver, spleen and kidney extracts. Each tissue extract was reintroduced into PBS (50 mg of lyophilized extract/ml) and centrifuged. Anti-liver serum was polvmerized without prior absorption. Two anti-NSA3 immunosorbents were prepared: Polymer 1 (polymerized monospecific liver-absorbed antiserum) and Polymer 2 (the antiserum which was previously absorbed with liver extract (i.e. as 1) was further absorbed with fibrosarcoma extract, and then polymerized).
Before polymerization the serum was tested and found not to react with mesenchymal tissue and tumours by immunoprecipitation or immunofluorescence, but to be still reactive with brain antigen by immunofluorescence. This Polymer 2 was controlled and found to have no binding activity to adenoma and fibrosarcoma extracts under the conditions described. All of these polymers were treated at pH 2-8 and used 10 times with no appreciable loss of activity. Before incubation with extracts, they were put into a syringe and pressure was applied to remove excess water.
Immunological methods.-Immunodiffusion was performed on agarose gels (1-5%) containing PBS. Holes 3 or 7 mm in diameter were cut. The diffusion was allowed to proceed for 48 h at room temperature. The gels were washed for 3 days in PBS. Slides were then dried and subsequently stained with Coomassie Blue, Schiff's reagent or Sudan Black.
Electrosyneresis (Bussard, 1959) was used under the conditions previously described (Delpech et al., 1976b) to detect NSA3 in column effluents without any concentration. The sensitivity threshold was about 1 u/ml. Antigen assay by precipitation inhibition: We used this technique rather than direct immunodiffusion in antibody-containing gel, because the latter is influenced by the degree of aggregation of proteins, leading to an underestimation of highly polymerized antigens. In addition, inhibition procedures are known to be more sensitive. We therefore assayed the antigens by the precipitationinhibition technique. Monoradial reverse immunodiffusion was used for antibody assay (Vaerman et al., 1969) which, by measuring the inhibition of the corresponding antibody, permits the assay of the antigen concentration of a given extract. A 2% solution of agarose in PBS at 56°C was added to an equal volume of either cerebral extract (2 mg/ml) or purified NSA3 (0.1 mg/ml). This mixture was poured into a glass slide supported by a horizontal surface. After solidification, 3mm diameter wells were cut into the gel and filled with the antiserum to be studied. At the end of 2 days' diffusion in a humid environment, the slides were washed in PBS, dried, and stained as described above. Precipitation ring diameters were measured with a graduated eye piece. Antigen assay was carried out in the following way: 30 ,ul of the extract to be studied containing 0 6-1 mg of proteins was removed with a Pipetman pipette (Gilson) and added to 30 ,l of monospecific antiserum. After standing for 24 h at room temperature, the mixture was centrifuged (3000 g for 15 min) and the supernatant deposited in the well. ,All assays were performed in duplicate. The reference antiserum was assigned a value of 100% (30 ,u of PBS was added to obtain the reference antiserum). After an efficient absorption, antisera gave a smaller ring or none at all. Antigen units were calculated according to the following formula:
S 100-S inhib.
Where S 100 =surface obtained with the reference antiserum, and S inhib. = surface obtained after incubation witlh extract. Based on 15 determinations, the significant threshold was calculated to be 12 units (P = 0.05).
Indirect immunofluorescence reaction.-Cubic fragments whose sides measured -5 mm were fixed in liquid N2 and stored at -80°C. The fragments were cut in a cryostat at -20°C. The sections were fixed in alcohol for 20 min at 40C. Before use the sections were rehydrated with PBS for 5 min. The sections were incubated in a humidified box at 37°C for 40 min -with 1: 5 and 1: 10 diluted antiserum. Sections were then washed with PBS x 3 at room temperature. Subsequenitly, fluorescent sheep anti-rabbit globulin (Institut Pasteur, Paris) was applied at a dilution of 1: 20 for 30 min at room temperature. Afterwards, the sections were w-ashed x 3 or x 5 with PBS and mounted with buffered glycerin. Counterstaining -was performed w-%ith Evans Blue. The controls consisted of nonimmunized rabbit serum, ani antiserum of another specificity reacting -with NSA2 (Delpech & Delpech, 1975) and the specific anti-NSA3 serum absorbed out ws%ith the purified antigen. In order to compare the cerebral antigen with tumour and foetal organ antigens, the diluted antiserum (1: 10) was absorbed out -with extracts the antigenic concentrations of which had been determined previously (Table 11) . Then the antiserum was tested on brain sections, foetal skin sections, breast-adenoma sections. and fibrosarcoma sections.
Physico-cheinical methods. antigen and NSA3 (Figs. 5, 6 ). However, antigen extracted from tumours was much less immunogenic than brain NSA3. Sera from only 2/10 rabbits immunized against adenoma and fibrosarcoma antigens could be used for immunochemical study. In these 2 cases, the antibody titre was 1/4 of the anti-NSA3 antibody titre. Further- 
Immunoftuorescence
Immunofluorescence studies confirmed tal brain. the presence and showed the localization ve result. in non-nervous tumours of an antigen id in ex-analogous to NSA3. In all positive cases, antigenic the specific fluorescence found with antin NSA3, NSA3 serum was not reproduced with the control sera. This specific fluorescent staining was localized in the fibrous stroma of the carcinomas; the cancer cells themselves presented no fluorescence (Fig. 5) . The tumours that gave negative results with precipitation inhibition gave positive results with immunofluorescence. Conversely, in the fibrosarcoma studies (Fig.  6 ) the antibodies marked the cellular region in tumours.
In breast adenofibromas, fluorescence was also seen in the fibrous part of the tumour, though the fluorescent staining was too imprecise to determine accurately (1 mg/ml). 3, Anti-CEA serum. 4, CEA (0-25 mg/ml). 5, Anti-NCA serum. 6, NCA (0-25 mg/ml) 7, Anti-asfoetoprotein serum. 8, oc-Foetoprotein. 9, Anti-GFA serum. 10, GFA (1 mg/ml). 11, Anti-lactoferrin serum. 12, Lactoferrin (0-25 mg/ml).
the antigenic localization within the region, i.e. whether in the cytoplasm, the cytoplasmic membrane or the intercellular space. This last hypothesis was supported by the negative cellular imprints of strongly positive tumours. In the foetal skin and intestine samples examined, the antigen was localized in the mesenchyme in the form of highly fluorescent large granules. Furthermore, by identical immunofluorescent techniques, this same antigen was also found in very narrowly defined zones of adult tissues (Delpech et al., 1978) : the lamina propria of the large intestine, the renal papilla, the intralobular connective tissue of the breast, the subendothelial layer of the uterus and the intima of arteries. In this last case, the immunofluorescent staining appeared to be clearly separate from the spontaneous fluorescence of the elastin. Therefore the antigen is clearly associated with mesenchyme and we have designated it "mesenchyme-associated antigen" (MAA). The cultured fibroblasts, however, were not labelled by the immunofluorescent antibody.
Inhibition tests Tests were undertaken in an attempt to distinguish between NSA3 and MAA. Although they appeared identical in immunodiffusion experiments (Fig. 2) , the results showed that the mesenchymal antigen is incapable of abolishing the antibodies' binding to nervous tissue in immunofluorescence reactions (Table II) 2 Electrophoretic mobilities in agarose were generally those of ox globulins, though sometimes faster. In crude extracts, antigens behaved as high-molecular-weight components that were partly disaggregated by lower pH (Delpech et al., 1976a, b) .
The amino-acid analysis of NSA3, adenoma MAA and fibrosarcoma MAA indicated similar compositions (Table III) . DISCUSSION An antigen reacting with anti-NSA3 antibodies has been shown to be present in mesenchyme (undifferentiated connective tissue), mainly that of foetal organs THR  SER  GLU  PRO  GLY  ALA  CYS  VAL  MET  ILEU  LEU   TYR   PHE  HIS  LYS  ARG   NSA3  95  57  68  113  47  127  74  7  62  3  33  88  26  34  26  58  44   Adenoma  MAA  97  59  76  124  37  119  82  15  65  7  33  90  27  37  26  64  40   Fibrosarcoma  MAA  107  61  67  131  52  97  84  13  70  6  31  91  18  38  23  65  37 and tumours. We designated it "mesenchyme-associated antigen" or MAA.
The first point to be discussed is the relationship between MAA and NSA3. The immunochemical and biochemical similarities between these antigens are obvious, yet differences do exist:
( (Abelev, 1963) or CEA (Gold & Freedman, 1965) . Marking this antigen permits quantification of the fibrousstroma reaction, a parameter that has so far eluded biochemical measurement. Morphometric evaluation of this stroma reaction has been made for breast carcinoma (Underwood, 1972) , where it was found to predominate in scirrous carcinoma. However, Underwood pointed out the unusual staining of immature connective tissue. Gerstl et al. (1974) studied lung carcinoma with Underwood's morphometric technique. Although they found it to be inapplicable to lung cancers, the authors demonstrated marked differences between stroma-rich epidermoid carcinomas and oat-cell carcinomas which were rather poor in stroma. The method described in the present paper is of particular interest in that it permits the marking of MAA, thus allowing a biochemical quantification of the immature, connective stroma reaction in carcinomas. This fact could be of significance in cancerology, since the precise nature of the stromatumour relation is poorly understood, though it has been shown that a component of connective tissue, as well as connective tissue itself, could inhibit tumour growth (Parshley & Mandl, 1965; Haddow, 1967) . The antigen's association with mesenchyme accounts for its presence in fibrosarcomas. In all our cases, the antigen localized in mesenchyme corresponds to intercellular rather than intracellular deposits. Nevertheless, the antigen was constantly present in mesenchyme, and constantly absent in non-mesenchymal tissues. In this respect, MAA can be considered as a fibrous tumour marker for both benign (breast adenoma), and malignant (fibrosarcoma) fibrous tumours. This association with mesenchyme, as well as the fibrillar aspect at times encountered in microscopy, could be construed as indicating that the antigen is merely a component of connective-tissue proteins. Its solubility in physiologic media, its resistance to collagenase and elastase, and its lack of cross-antigenicity, demonstrate that MAA is neither collagen nor elastin. Therefore, MAA is probably a glycoprotein whose structure is associated with the ground substance. The amino-acid composition is comparable to that of many varieties of these glycoproteins (Anderson, 1976) . The glycoproteins are partially soluble in physiological media, are associated with collagen, and are more abundant in the embryo and foetus than in the adult, as has been demonstrated in animal studies (Robert et al., 1976) .
NSA3 and MAA must be compared to CEA and the antigens that cross-react with CEA (Burtin, 1978) . This latter group of glycoproteins is associated with human tumours and, in spite of their strong cross-reaction, are present in different cellular varieties: CEA was found in macrophages and polymorphs (Burtin et al., 1975) as well as in cancer cells (Burtin et al., 1973) . Similarly, NSA3 and MAA, which share a large part of their antigenic determinants, are present in different tissues. NSA3 is a nervous-system antigen, while MAA is present in cancer and foetal stroma, and in some adult connective tissues. However, the tissue localization is completely different from that of CEA and NCA. Furthermore, anti-CEA and anti-NCA antibodies do not react with NSA3 and MAA. Therefore, we conclude that the NSA3-MAA system is an antigenic system distinct from the CEA-NCA system. Other tissue and tumour-associated antigens should be compared: xZ H globulin (ferritin) was first discovered in sera from cancer patients (Buffe et al., 1970) and is a major component of foetal liver (Buffe & Rimbaut 1975) . Lactoferrin, which is associated with polymorphs (Masson, 1970) , was also found in tumours (Loisilier et al., 1971) including brain tumours (Delpech & Buffe, 1972) . 2 Microglobulin, a urinary protein (Berggard & Bearn, 1968) and a component of the HLA system, was found in various human tissues (Governa & Biguzzi, 1976) . Fibronectin, a fibroblast surface protein (Ruoslahti et al., 1973) was found to bind to collagen (Engvall & Ruoslahti, 1977) . Glial fibrillary acidic protein, a specific marker for astrocytes, was also found in gliomas (Delpech et al., 1978; Eng & Rubinstein, 1978) . Apart from the histological features described in the literature, which distinguish these antigens from MAA and NSA3, the immunoprecipitation tests showed clearly that they are not identical to MAA. MAA can be considered as a new oncofoetal marker for mesenchymal tissue.
